Evidence map›Paper›PMID 11535139›Full record

ArticleThe Biochemical journal2001

Phosphorylation of the leucocyte NADPH oxidase subunit p47(phox) by casein kinase 2: conformation-dependent phosphorylation and modulation of oxidase activity.

H S Park, S M Lee, J H Lee, Y S Kim, Y S Bae, J W Park

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. S-Nitrosylation of p47(phox) enhances phosphorylation by casein kinase 2.Redox report : communications in free radical research · 2015
    Article
  7. Review
  8. Article
  9. Review
  10. Cell signaling through protein kinase C oxidation and activation.International journal of molecular sciences · 2012
    Review
  11. Endothelial dysfunction in diabetes: multiple targets for treatment.Pflugers Archiv : European journal of physiology · 2010
    Review
  12. CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  13. Review
  14. Small interfering peptide (siP) for in vivo examination of the developing lung interactonome.Developmental dynamics : an official publication of the American Association of Anatomists · 2009
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

H S ParkDepartment of Biochemistry, College of Natural Sciences, Kyungpook National University, Taegu 702-701, Korea.
S M Lee
J H Lee
Y S Kim
Y S Bae
J W Park
Kyungpook National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The leucocyte NADPH oxidase of neutrophils is a membrane-bound enzyme that catalyses the reduction of oxygen to O(-)(2) at the expense of NADPH. The enzyme is dormant in resting neutrophils but becomes active when the cells are exposed to the appropriate stimuli. During oxidase activation, the highly basic cytosolic oxidase component p47(phox) becomes phosphorylated on several serines and migrates to the plasma membrane. Protein kinase CK2 is an essential serine/threonine kinase present in all eukaryotic organisms. The leucocyte NADPH oxidase subunit p47(phox) has several putative CK2 phosphorylation sites. In the present study, we report that CK2 is able to catalyse the phosphorylation of p47(phox) in vitro. Phosphoamino acid analysis of phosphorylated p47(phox) by CK2 indicated that the phosphorylation occurs on serine residues. CNBr mapping and phosphorylation of peptides containing the putative site of CK2 indicated that the main phosphorylated residues are Ser-208 and Ser-283 in the Src homology 3 (SH3) domains, and Ser-348 in the C-terminal domain of p47(phox). Dependence of phosphorylation on the conformation of p47(phox) is supported by the finding that p47(phox) undergoes better phosphorylation by CK2 in the presence of arachidonic acid, a known activator of NADPH oxidase which induces conformational changes in p47(phox). In addition, 5,6-dichloro-1-beta-o-ribofuranosyl benzimidazole, a CK2 inhibitor, potentiates formyl-Met-Leu-Phe-induced NADPH oxidase activity in DMSO-differentiated HL-60 cells. Taken together, we propose that CK2 is the p47(phox) kinase, and that phosphorylation of p47(phox) by CK2 regulates the deactivation of NADPH oxidase.

Indexed as

Amino Acid SequenceArachidonic AcidCasein Kinase IICell DifferentiationCell MembraneCloning, MolecularDichlororibofuranosylbenzimidazoleDimethyl SulfoxideEnzyme InhibitorsEscherichia coliHL-60 CellsHumansMultienzyme ComplexesNADH, NADPH OxidoreductasesNADPH OxidasesNeutrophilsArachidonic AcidCasein Kinase IIDichlororibofuranosylbenzimidazoleDimethyl SulfoxideEnzyme InhibitorsMultienzyme ComplexesNADH, NADPH OxidoreductasesNADH oxidaseNADPH Oxidasesneutrophil cytosolic factor 1N-Formylmethionine Leucyl-PhenylalanineOligopeptidesPhosphoproteinsProtein Serine-Threonine KinasesProtein SubunitsRecombinant ProteinsSuperoxides

Identifiers

PMID11535139
PMCPMC1222112
OpenAlexW2009063566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.